Pacira BioSciences Files 8-K on Financials
Ticker: PCRX · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: PCRX
TL;DR
Pacira BioSciences dropped an 8-K on Jan 10th covering financials - check it out!
AI Summary
Pacira BioSciences, Inc. filed an 8-K on January 10, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date as of change both being January 10, 2025. The company is incorporated in Delaware and headquartered in Tampa, Florida.
Why It Matters
This 8-K filing provides an update on Pacira BioSciences' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- January 10, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Tampa, Florida (location) — Principal Executive Offices
- Pacira Pharmaceuticals, Inc. (company) — Former Company Name
- PACIRA INC (company) — Former Company Name
- Blue Acquisition Corp (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Pacira BioSciences, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on January 10, 2025.
In which state is Pacira BioSciences, Inc. incorporated?
Pacira BioSciences, Inc. is incorporated in Delaware.
What are the principal executive offices of Pacira BioSciences, Inc.?
The principal executive offices of Pacira BioSciences, Inc. are located at 5401 West Kennedy Boulevard, Suite 890, Tampa, Florida 33609.
Has Pacira BioSciences, Inc. operated under different names previously?
Yes, Pacira BioSciences, Inc. has previously operated under the names Pacira Pharmaceuticals, Inc., PACIRA INC, and Blue Acquisition Corp.
Filing Stats: 496 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-01-10 08:01:45
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share PCRX Nasdaq Global Select Mar
Filing Documents
- pcrx-20250110.htm (8-K) — 24KB
- pcrx-2024revenuepressrelea.htm (EX-99.1) — 39KB
- paciralogo2025a.jpg (GRAPHIC) — 80KB
- 0001396814-25-000011.txt ( ) — 307KB
- pcrx-20250110.xsd (EX-101.SCH) — 2KB
- pcrx-20250110_lab.xml (EX-101.LAB) — 22KB
- pcrx-20250110_pre.xml (EX-101.PRE) — 13KB
- pcrx-20250110_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 10, 2025, Pacira BioSciences, Inc. issued a press release announcing its preliminary unaudited revenue for the fourth quarter and full-year ended December 31, 2024. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release dated January 10, 2025. 104 Cover Page Interactive Data File (Formatted as Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PACIRA BIOSCIENCES, INC. (REGISTRANT) Dated: January 10, 2025 By: /s/ KRISTEN WILLIAMS Kristen Williams Chief Administrative Officer and Secretary